Inhalable oridonin-loaded poly(lactic-co-glycolic)acid large porous microparticles for in situ treatment of primary non-small cell lung cancer

• Prif Awduron: Lifei Zhu (Awdur), Miao Li (Awdur), Xiaoyan Liu (Awdur), Lina Du (Awdur), Yiguang Jin (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Elsevier, 2017-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancers. Traditional chemotherapy for this disease leads to serious side effects. Here we prepared an inhalable oridonin-loaded poly(lactic-co-glycolic)acid (PLGA) large porous microparticle (LPMP) for in situ treatment of NSCLC w...